Highly Specific Cartilage-Targeting Imaging Agents for Early Detection of Arthritis

Description

This technology is a new class of dyes designed for cartilage-specific imaging in the near-infrared-II (NIR-II) window. Currently, there is a lack of tissue-specific diagnostic methods for early detection of arthritis, and of clinically available, high quality, cartilage contrast agents.  This lack of early diagnostic capability means that diagnosis of arthritis occurs at later stages of disease, potentially leading to irreversible joint damage and reduced treatment efficacy.

This technology meets the important need for earlier diagnosis with dyes that demonstrate a high affinity for cartilage tissue and offer superior imaging capabilities, with minimal tissue scattering and autofluorescence. The dyes demonstrate low toxicity and high specificity, making them promising imaging agents for clinical diagnostics and tools for research in joint diseases.

 

Benefits

  • Specific– high cartilage-specific affinity enabling precise imaging
  • Low Background – operates in the NIR-II window for minimal tissue scattering and autofluorescence
  • Low Toxicity – low toxicity levels in both in vitro and in vivo models

 

Applications

  • Diagnostic imaging for early detection of degenerative joint diseases
  • Tissue engineering and regenerative medicine
  • Enhanced guidance for joint surgery procedures
  • Drug development and efficacy testing for inflammatory joint diseases

 

Patent Status

  • Pending Provisional patent application

 

Publications

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4909413

Patent Information:
Category(s):
Imaging
Research Tool
For Information, Contact:
Kenneth Franklin
Senior Licensing Associate
Georgia State University
kfranklin31@gsu.edu
Inventors:
Maged Henary
Hak Soo Choi
Homan Kang
Keywords:
© 2025.   All Rights Reserved. Georgia State University. Powered by Inteum